Related Experiment Video
Updated: Jun 26, 2025

10:33
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
2.7K
Clinical Insights: Antimicrobial Therapy for Infectious Uveitis.
Evangeline Leong1, Carlos Cifuentes-González2,3, Jeremy Hu Y W3
1Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Ocular Immunology and Inflammation
|May 17, 2024
Summary
Infectious uveitis, a leading cause of vision loss, presents treatment challenges. This review details current antimicrobial therapies for infectious uveitis, focusing on clinical applications.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Infectious uveitis is a significant global cause of vision impairment.
- The eye's immune privilege is challenged by pathogens like bacteria, viruses, fungi, and parasites, leading to ocular infections.
- Clinical management of infectious uveitis is often complicated by limited or ineffective treatment options.
Purpose of the Study:
- To provide recent updates on antimicrobial therapies for infectious uveitis.
- To review treatment strategies from a clinical perspective.
- To cover topical, systemic, and regional treatments for infectious uveitis.
Main Methods:
- Review of current literature on antimicrobial therapies for infectious uveitis.
- Analysis of diagnostic and assessment tools, including molecular techniques and imaging.
- Evaluation of existing antimicrobial treatments, considering drug concentration, penetration, duration, toxicity, and side effects.
Main Results:
- Antimicrobial therapies for infectious uveitis face challenges related to drug delivery and efficacy.
- Treatment approaches must be tailored to the specific etiology of the infection.
- Modern diagnostics aid in identifying intraocular infections.
Conclusions:
- Effective management of infectious uveitis requires addressing limitations in current antimicrobial therapies.
- Tailoring treatment based on causative agents and optimizing drug delivery are crucial.
- Continued research and clinical updates are necessary for improving outcomes in infectious uveitis.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Open Angle Glaucoma: Treatment
432
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
432
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K

